HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany Begins The Year With Two Possible Rx-To-OTC Switches

Executive Summary

Germany's Expert Committee for Prescription will meet on 22 January to consider two prescription-to-OTC switch applications: preparations containing a combination of ibuprofen and phenylephrine hydrochloride and hydrocortisone 1% for external use. 
Advertisement

Related Content

Surviving The Dark German Winter: Four New Dietary Supplements Containing Vitamin D
Germany Marketing Round Up December 2018: New OTC Products For The Winter Cough and Cold Season
An Expert’s Guide To Switching In Germany, Part 2: Improving The Reclassification Process
An Expert’s Guide To Switching In Germany, Part 1: Navigating The Reclassification Process

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS148411

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel